CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
RocketAP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04545567
NCT04545567N/ACompleted
CompareCT.gov

Fully Automated Closed Loop Control in Adolescents With Type 1 Diabetes (Rocket AP)

University of Virginia·interventional·Posted Sep 11, 2020·Updated Apr 20, 2022

In Brief

A clinical study evaluating RocketAP and USS Virginia for Type 1 Diabetes. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The study team will be comparing two investigational Artificial Pancreas (AP) systems that the UVA Center for Diabetes Technology has developed. An artificial pancreas system delivers insulin automatically based on a blood glucose level that is provided from a continuous glucose monitor (CGM).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 11, 2020
Enrollment StartDec 16, 2020
Primary CompletionJan 18, 2021
Study CompletionJan 21, 2021
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 5.8 years ago

Interventions

RocketAPdevice

Artificial pancreas system which is designed to be able to identify when you have eaten and provide insulin for this meal

USS Virginiadevice

Artificial pancreas system which responds to glucose fluctuations by modulating insulin delivery but does not specifically detect meal ingestion